ReviewHarm reduction journal2015
Drug-related HIV epidemic in Pakistan: a review of current situation and response and the way forward beyond 2015.
Review in Harm reduction journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- An update on bloodborne viruses among people who inject drugs in South Asia.Harm reduction journal · 2026Review
- Notable transmitted HIV drug resistance among people who inject drugs in Pakistan.The Journal of antimicrobial chemotherapy · 2026Article
- Unveiling the dynamics: understanding the current scenario and drivers of HIV epidemiology in Pakistan.Retrovirology · 2025Review
- Risk factors of HIV and variation in access to clean needles among people who inject drugs in Pakistan.Pathogens and global health · 2023Article
- The surge of HIV in Pakistan: an epidemic or a progressive transmission in denial? An editorial.Annals of medicine and surgery (2012) · 2023Article
- Elucidating Drivers for Variations in the Explosive Human Immunodeficiency Virus Epidemic Among People Who Inject Drugs in Pakistan.Open forum infectious diseases · 2021Article
- The association of HIV and easy access to narcotics in Pakistan; calling drug policy makers.Journal of pharmaceutical policy and practice · 2019Article
- Prevalence and associated risk factors of HIV in prisons in Balochistan, Pakistan: a cross-sectional study.F1000Research · 2018Article
- From conflict to partnership: growing collaboration between police and NGOs in countries with concentrated epidemics among key populations.Journal of the International AIDS Society · 2016Article
- Harm reduction in Asia and the Pacific: an evolving public health response.Harm reduction journal · 2015Article
- Rising HIV seroconversion rates & associated risks among employees of organization 'X': A case control study, Pakistan, 2017.Pakistan journal of medical sciencesArticle
- Prevalence of human immunodeficiency virus and Hepatitis (B & C) among drug users in a tertiary care public hospital.Pakistan journal of medical sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pakistan is among four countries in Asia where the estimated number of new HIV infections has been increasing year by year ever since 1990. The Asian Epidemic Modelling (AEM), conducted in 2015, reconfirmed that the use of contaminated injection equipment among people who inject drugs (PWID) remains the main mode of HIV transmission in the country. The estimated number of PWID ranges from 104,804 to 420,000 PWID. HIV prevalence in this population is above 40 % in several cities, including Faisalabad (52.5 %), D.G. Khan (49.6 %), Gujrat (46.2 %), Karachi (42.2 %) and Sargodha (40.6 %), respectively. Harm reduction service delivery is being implemented through a public-private partnership led by the National and Provincial AIDS Control Programmes and Nai Zindagi with funding support from the Global Fund. Current programmatic coverage of the needle and syringe programme, HIV testing and counselling and antiretroviral treatment among PWID remain insufficient to control ongoing transmission of HIV in the country. While opioid substitution therapy (OST) is yet to be introduced, significant progress and coordination among various ministries have taken place recently to register buprenorphine in the dosage required for treatment of opioid dependence, and possible introduction of OST will greatly facilitate adherence to antiretroviral treatment among PWID living with HIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.